From: OncLive <edigest@onclive.com>
Sent: <Day, Month xx, 2020>
To: <<Email Address>>
Subject: Save the Date for a Live Broadcast on a New Combination Treatment for Patients with aRCC

No Images? Click here

Exelexis

LIVE BROADCAST
[Month, Date, Year 00:00 (EST)]

 

Discover a New Combination Treatment for Patients With Advanced Renal Cell Carcinoma

OncLive® invites you to join the experts for a live broadcast to learn about a new combination regimen for the treatment of advanced renal cell carcinoma (aRCC). In this broadcast, thought leaders will review the epidemiology of RCC, discuss mechanisms of action of a multitargeted approach to treatment, review the efficacy and safety data for a new combination regimen, and share clinical insights through a live Q&A.

    REGISTER TODAY    

This program is intended for US Healthcare Professionals including: Oncologists, NPs, PAs, RNs, Pharmacists. Program is not intended for non-healthcare professionals, including guests or spouses.

Join these speakers:

Exelexis

[Fullname, Credentials]

[Faculty Title]
[Faculty Institution]
[Faculty City, State]

Exelexis

[Fullname, Credentials]

[Faculty Title]
[Faculty Institution]
[Faculty City, State]

Exelexis

[Fullname, Credentials]

[Faculty Title]
[Faculty Institution]
[Faculty City, State]

REGISTER TODAY
Exelexis
Exelexis

CA-1715       09/20

This program is not certified for Continuing Medical Education credit.

This program is intended for US Healthcare Professionals including: Oncologists, NPs, PAs, RNs, Pharmacists. Program is not intended for non-healthcare professionals, including guests or spouses.

 

OncLive® – an MJH Life Sciences brand
Copyright 2020 © Intellisphere, LLC
2 Clarke Dr | Suite 100 | Cranbury, NJ | 08512

Preferences  |  Unsubscribe

  Forward